Lausanne, Switzerland

Jan Peter Henning STÖHR

This inventor holds 1 USPTO granted patent. Top assignee: Ac Immune Sa. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jan Peter Henning STÖHR. Retrieved from https://idiyas.com/inventor/jan-peter-henning-stöhr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jan Peter Henning Stöhr: Innovator in Therapeutic Molecules

Introduction

Jan Peter Henning Stöhr is a notable inventor based in Lausanne, Switzerland. He has made significant contributions to the field of therapeutic and diagnostic molecules. His work is recognized for its potential impact on medical science and patient care.

Latest Patents

Stöhr holds a patent for "Novel Molecules for Therapy and Diagnosis." This patent represents his innovative approach to developing new therapeutic options that could enhance diagnostic capabilities in medicine. He has 1 patent to his name, showcasing his commitment to advancing healthcare solutions.

Career Highlights

Stöhr is currently employed at AC Immune SA, a company known for its focus on developing innovative therapies for neurodegenerative diseases. His role at AC Immune SA allows him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Throughout his career, Stöhr has worked alongside talented individuals such as Elpida Tsika and John Warner. These collaborations have fostered a dynamic environment for innovation and have led to significant advancements in their respective fields.

Conclusion

Jan Peter Henning Stöhr is a distinguished inventor whose work in novel therapeutic molecules holds promise for the future of medicine. His contributions continue to inspire advancements in healthcare and diagnostics.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…